42.0.0.26 â Redirect Fix (Removed pre-redirect output)
DEBUG LOG â klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1069285
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 17399591-b4f1-4eb0-bfa7-4c955840ec50
[Document ID] => 1069285
[Document naam] => FW: EU COVID-19 Vaccine AstraZeneca recommended for use in the EU
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1069285
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1069285
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
[DocumentPublicationDate] => 29 januari 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 05:47:05
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 05:47:05
)
Document: VWS-WOO-08-1069285
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210129
Geregistreerde documentnaam: FW: EU COVID-19 Vaccine AstraZeneca recommended for use in the EU
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-10-24 17:03:33 |
| About_Gelakte gegevens_linkhref_3 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-10-24 17:03:33 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory | 2025-10-24 17:03:33 |
| document_SectionDownloadButton | 1 | 2025-10-24 17:03:33 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2025-10-24 17:03:33 |
| Request_Omvang publicatie | 15.371 documenten waarvan 7.083 openbaar gemaakt Inventarislijst | 2025-10-24 17:03:33 |
| Request_Omvang publicatie_paginas | 15.371 | 2025-10-24 17:03:33 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:41:38 |
| document_documentName | FW: EU COVID-19 Vaccine AstraZeneca recommended for use in the EU | 2025-06-22 23:41:38 |
| document_documentType | E-mailbericht | 2025-06-22 23:41:38 |
| document_documentPublicationDate | 2021-01-29 | 2025-06-22 23:41:38 |
| document_documentNumber | VWS-WOO-08-1069285 | 2025-06-22 23:41:38 |
| document_SectionHTMLDataDivs | 4 | 2025-06-22 23:41:38 |
| document_SectionAbout | 1 | 2025-06-22 23:41:38 |
| About_Datum document | 29 januari 2021 | 2025-06-22 23:41:38 |
| About_Type bronbestand | E-mailbericht, 2 pagina's | 2025-06-22 23:41:38 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:41:38 |
| About_Download als | PDF (923.2 KB) | 2025-06-22 23:41:38 |
| About_Documentnummer | 1069285 | 2025-06-22 23:41:38 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkhref_2 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkname_2 | 5.1.5 Het voorkomen van onevenredige benadeling | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkname_3 | Laat het ons weten | 2025-06-22 23:41:38 |
| document_SectionAttachments | 1 | 2025-06-22 23:41:38 |
| document_SectionRequest | 1 | 2025-06-22 23:41:38 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 2021 | 2025-06-22 23:41:38 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo | 2025-06-22 23:41:38 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 2021 | 2025-06-22 23:41:38 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:41:38 |
| Request_Periode | Januari 2021 | 2025-06-22 23:41:38 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:41:38 |
| Request_Datum besluit | 19 december 2022 | 2025-06-22 23:41:38 |
| document_SectionHistory | 1 | 2025-06-22 23:41:38 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 19 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode januari 2021. | 2025-06-22 23:41:38 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:41:38 |
| About_Gelakte gegevens_linkhref_3 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over FW: EU COVID-19 Vaccine AstraZeneca recommended for use in the EU (documentnummer 1ee694c1-ce8c-63aa-ac1c-b5de068c5498) | 2025-06-22 23:41:38 |
| Request_Omvang openbaarmaking | 15.371 documenten, 25.508 pagina's Inventarislijst | 2025-06-22 23:41:38 |
| Request_Omvang openbaarmaking_documenten | 15.371 | 2025-06-22 23:41:38 |
| Request_Omvang openbaarmaking_paginas | 25.508 | 2025-06-22 23:41:38 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory | 2025-06-22 23:41:38 |
| History Actie_2 | Opschorting opgeheven | 2025-06-21 03:59:08 |
| History Datum_2 | 31 oktober 2024 15:26 | 2025-06-21 03:59:08 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 923.2 KB) | 2025-06-21 03:59:08 |
| History Datum_1 | 31 oktober 2024 15:29 | 2025-06-21 03:59:08 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/document/1ee694c1-ce8c-63aa-ac1c-b5de068c5498 | 2025-04-19 22:53:19 |
| DocumentDownload_linkname | Download (pdf, 923.2 KB) | 2025-04-19 22:53:19 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1069285.pdf | 2025-04-19 22:53:19 |
Archiefversies (6 rijen)
Archiefrij 1 â 2025-09-07 17:22:44
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1069285.pdf
documentName: VWS-WOO-08-1069285.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 945352
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:22:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:22:44
lastSeen: 2025-09-07 17:22:44
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3780daf23047f941ebe6aa4e049194280d8753e0543a9dbe7d1b8157bb7bbd4
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: folder_import_33523_bfc981051513b0e4d75cea7b39ce51e0
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
Archiefrij 2 â 2025-09-04 17:03:04
fromFile: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
documentName: VWS-WOO-08-1069285.pdf
documentType: pdf
documentCompressedSize: 629336
documentSize: 945352
documentCompressRatio: 66.57160507408881
documentDateModified: 2025-05-01 20:42:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:03:04
lastSeen: 2025-09-04 17:03:04
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3780daf23047f941ebe6aa4e049194280d8753e0543a9dbe7d1b8157bb7bbd4
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip_3460
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
Archiefrij 3 â 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf
documentType: pdf
documentCompressedSize: 627793
documentSize: 945352
documentCompressRatio: 66.40838544796013
documentDateModified: 2024-11-14 10:51:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 331542
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
Archiefrij 4 â 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf
documentType: pdf
documentCompressedSize: 627793
documentSize: 945352
documentCompressRatio: 66.40838544796013
documentDateModified: 2024-11-14 10:51:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
documentMailAdresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
digestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 244630
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
Archiefrij 5 â 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
documentName: VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf
documentType: pdf
documentCompressedSize: 627793
documentSize: 945352
documentCompressRatio: 66.40838544796013
documentDateModified: 2024-11-14 10:51:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
documentMailAdresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
digestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 114254
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
Archiefrij 6 â 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
documentName: VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf
documentType: pdf
documentCompressedSize: 627793
documentSize: 945352
documentCompressRatio: 66.40838544796013
documentDateModified: 2024-10-31 16:05:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1069285
To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e
Sent:Fri1/29/2021 6:17:39 PM
Subject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU
Received:Fri1/29/2021 6:17:40 PM
image001.ipg
AZD1222 EMA recomendation RNS. pdf
| |
Ministerie van Volksgezondheid, WelzijnenSpo
P...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
documentMailAdresses: [{"position": 17, "email": "ERED@minvws.ni", "context": "1069285 To: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e"}, {"position": 462, "email": "@minvws.nl", "context": ")SEER inv nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e"}, {"position": 481, "email": "@minvws.ni", "context": "nb;IEE @minvws.nl> )<BEEE @minvws.ni>;512 5.1.2e Onderwerp: FW:"}, {"position": 645, "email": "@minvws.nl", "context": "29januari 2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>;"}, {"position": 657, "email": "@minvws.nl", "context": "2021 18:43 @minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp:"}, {"position": 673, "email": "@minvws.nl", "context": "@minvws.nl> @minvws.nl>; BE @minvws.nl>; Onderwerp: FW: EUCOVID-19"}, {"position": 1012, "email": "@astrazeneca.com", "context": "vanVWS ninvws.nl> Ce:TEE (@astrazeneca.com> Onderwerp: EUCOVID-19 Vaccine"}, {"position": 1936, "email": "I@astrazeneca.com", "context": "5.1.21 5.1.2e [5120 I@astrazeneca.com pAIEE ETI T+oroENEIEEETI."}]
digestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 67921
textDigestSHA256: d32b5c4ac06f79869daf0cedca51724c17115c59ca6c05690f84480a174fa84d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1069285
(dit is ook een speeltuin)